lncRNA PRR34-AS1 promotes HCC development via modulating Wnt/β-catenin pathway by absorbing miR-296-5p and upregulating E2F2 and SOX12

• Үндсэн зохиолчид: Minzhen Qin (Зохиогч), Yiliang Meng (Зохиогч), Chunying Luo (Зохиогч), Shougao He (Зохиогч), Fengxue Qin (Зохиогч), Yixia Yin (Зохиогч), Junling Huang (Зохиогч), Hailiang Zhao (Зохиогч), Jing Hu (Зохиогч), Zhihua Deng (Зохиогч), Yiying Qiu (Зохиогч), Gaoyu Hu (Зохиогч), Hanhe Pan (Зохиогч), Zongshuai Qin (Зохиогч), Zansong Huang (Зохиогч), Tingzhuang Yi (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Elsevier, 2021-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Hepatocellular carcinoma (HCC) belongs to the most frequent cancer with a high death rate worldwide. Thousands of long non-coding RNAs (lncRNAs) have been confirmed to influence the development of human cancers, including HCC. Nevertheless, the biological role of PRR34 antisense RNA 1 (PRR34-AS1) in...